ToxSci Advance Access published online on July 25, 2003
Toxicological Sciences, doi:10.1093/toxsci/kfg204
Toxicological Sciences © Society of Toxicology 2003; all rights reserved
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Integrated Toxicology Program, Duke University Medical Center, Durham, NC 27710; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710
* To whom correspondence should be addressed. E-mail: edlevin{at}duke.edu.
While risk assessment models attempt to predict human risk to toxicant exposure, in many cases these models cannot account for the wide variety of human response. This review addresses several primary sources of heterogeneity that may affect individual response to drug or toxicant exposure. Consideration was given to genetic polymorphisms, age related factors during development and senescence, gender differences associated with hormonal function, and preexisting diseases influenced by toxicant exposure. These selected examples demonstrate the need for additional steps in risk assessment that are needed to more accurately predict human response to toxicants and drugs.
© 2003 Society of Toxicology
Review
Heterogeneity of Toxicant Response: Sources of Human Variability
2 Integrated Toxicology Program, Duke University Medical Center, Durham, NC 27710; Biological Chemistry Program, Duke University Medical Center, Durham, NC 27710; Department of Chemistry, Duke University, Durham, NC 27708
3 Integrated Toxicology Program, Duke University Medical Center, Durham, NC 27710; Nicholas School of the Environment, Duke University Marine Laboratory, Beaufort, NC 28516
4 Integrated Toxicology Program, Duke University Medical Center, Durham, NC 27710; Department of Psychiatry, Duke University Medical Center, Durham, NC 27710
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Lofgren, R. M. Baldwin, M. Carleros, Y. Terelius, R. Fransson-Steen, J. Mwinyi, D. J. Waxman, and M. Ingelman-Sundberg Regulation of Human CYP2C18 and CYP2C19 in Transgenic Mice: Influence of Castration, Testosterone, and Growth Hormone Drug Metab. Dispos., July 1, 2009; 37(7): 1505 - 1512. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. M. Vickers Characterization of Hepatic Mitochondrial Injury Induced by Fatty Acid Oxidation Inhibitors Toxicol Pathol, January 1, 2009; 37(1): 78 - 88. [Abstract] [Full Text] [PDF] |
||||

